The Latest in Lymphoma & Plasma Cell Disorders

FDA issues CRL for IV formulation of antiemetic agent

January 14, 2017

Venetoclax approved to treat CLL in Australia

January 12, 2017

Combo granted orphan designation for CLL

January 10, 2017

Yoga may improve QOL in kids with cancer

January 6, 2017

US cancer cases may near 1.7 million in 2017

January 6, 2017

Cancer genomic data released to public

January 6, 2017

Drug eases existential anxiety in cancer patients

January 4, 2017

Intervention relieves distress in cancer patients

January 4, 2017

Drugs may be effective against hematologic, other cancers

January 2, 2017

Salvage regimens appear comparable in DLBCL

December 30, 2016

Company withdraws MAA for biosimilar pegfilgrastim

December 29, 2016

Combo produces high response rate in CLL trial

December 24, 2016

Bendamustine approved for new indication in Japan

December 23, 2016

G-CHOP no better than R-CHOP in previously untreated DLBCL

December 22, 2016

Combined checkpoint blockade promising in HL

December 22, 2016